BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jakate K, Azimi F, Ali RH, Lee C, Clarke BA, Rasty G, Shaw PA, Melnyk N, Huntsman DG, Laframboise S, Rouzbahman M. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol 2013;26:95-105. [DOI: 10.1038/modpathol.2012.136] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Fujii T, Takeda M, Uchiyama T, Nitta Y, Maebou K, Terada C, Okada F, Matsuoka M, Sugimoto S, Sasaki S, Morita K, Itami H, Miyake M, Takeda M, Sawabata N, Fujimoto K, Ohbayashi C. Identification of fusion transcripts in sarcoma from archival formalin-fixed paraffin-embedded tissues: A next-generation sequencing approach. Pathol Int 2022. [PMID: 35975909 DOI: 10.1111/pin.13265] [Reference Citation Analysis]
2 Tirrò E, Martorana F, Micale G, Inzerilli N, Carciotto R, Romano C, Longhitano C, Motta G, Lanzafame K, Stella S, Massimino M, Vitale SR, Salvatorelli L, Magro G, Manzella L, Vigneri P. Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience. Pathology - Research and Practice 2022;232:153820. [DOI: 10.1016/j.prp.2022.153820] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yoshida H, Kikuchi A, Tsuda H, Sakamoto A, Fukunaga M, Kaku T, Yoshida M, Shikama A, Kogata Y, Terao Y, Tanikawa M, Yasuoka T, Chiyoda T, Miyamoto T, Okadome M, Nakamura T, Enomoto T, Konno Y, Yahata H, Hirata Y, Aoki Y, Tokunaga H, Usui H, Yaegashi N. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese Clinical Oncology Group. Hum Pathol 2022:S0046-8177(22)00073-9. [PMID: 35339567 DOI: 10.1016/j.humpath.2022.03.007] [Reference Citation Analysis]
4 Yamaguchi K. Personalized Treatment in Uterine Sarcoma. Personalization in Gynecologic Oncology 2022. [DOI: 10.1007/978-981-19-4711-7_4] [Reference Citation Analysis]
5 Chiang S, Vasudevaraja V, Serrano J, Stewart CJR, Oliva E, Momeni-Boroujeni A, Jungbluth AA, Da Cruz Paula A, da Silva EM, Weigelt B, Park KJ, Soslow RA, Murali R, Ellenson LH, Benayed R, Ladanyi M, Abu-Rustum NR, Dickson MA, Cohen S, Aghajanian C, Hensley ML, Lee CH, Snuderl M, Konner JA. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition. Mod Pathol 2021. [PMID: 34561551 DOI: 10.1038/s41379-021-00922-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Yoon JY, de Kock L, Stewart CJR, McCluggage WG, Foulkes WD, Clarke BA, Rouzbahman M. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma. Cancer Treat Res Commun 2021;27:100363. [PMID: 33838572 DOI: 10.1016/j.ctarc.2021.100363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Burdett N, Bae S, Hamilton A, Desai J. The Role of Systemic Therapies in the Management of Soft Tissue Sarcoma. Sarcoma 2021. [DOI: 10.1007/978-981-15-9414-4_11] [Reference Citation Analysis]
8 Fujiishi K, Nagata S, Kano R, Kubo C, Shirayanagi M, Ozaki M, Yamamoto T, Nakanishi K, Kamiura S, Nakatsuka SI. JAZF1-SUZ12 endometrial stromal sarcoma forming subserosal masses with extraordinary uptake of fluorodeoxyglucose on positron emission tomography: a case report. Diagn Pathol 2019;14:110. [PMID: 31615558 DOI: 10.1186/s13000-019-0897-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Agaimy A, Moskalev EA, Weisser W, Bach T, Haller F, Hartmann A. Low-grade Endometrioid Stromal Sarcoma of the Paratestis: A Novel Report With Molecular Confirmation of JAZF1/SUZ12 Translocation. Am J Surg Pathol 2018;42:695-700. [PMID: 29394168 DOI: 10.1097/PAS.0000000000001030] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
11 Dickson BC. Beyond Smooth Muscle-Other Mesenchymal Neoplasms of the Uterus. Surg Pathol Clin 2019;12:107-37. [PMID: 30709439 DOI: 10.1016/j.path.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
13 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
14 Aisagbonhi O, Harrison B, Zhao L, Osgood R, Chebib I, Oliva E. YWHAE Rearrangement in a Purely Conventional Low-grade Endometrial Stromal Sarcoma that Transformed Over Time to High-grade Sarcoma: Importance of Molecular Testing. International Journal of Gynecological Pathology 2018;37:441-7. [DOI: 10.1097/pgp.0000000000000451] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
15 Köhler G, Zygmunt MT. Uterine Sarcomas and Atypical Smooth-Muscle Tumors: Clinic, Diagnostics and Appropriate Surgical Therapy. Hysterectomy 2018. [DOI: 10.1007/978-3-319-22497-8_14] [Reference Citation Analysis]
16 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
17 Lax SF. [New features in the 2014 WHO classification of uterine neoplasms]. Pathologe 2016;37:500-11. [PMID: 27738815 DOI: 10.1007/s00292-016-0230-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
18 Davidson B, Micci F. Molecular characteristics of uterine sarcomas. Expert Rev Mol Diagn 2017;17:515-22. [PMID: 28335657 DOI: 10.1080/14737159.2017.1311790] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
19 Muñoz-zuluaga CA, Sipok A, Sardi A. Management of Peritoneal Metastasis from Uterine Sarcoma. Unusual Cases in Peritoneal Surface Malignancies 2017. [DOI: 10.1007/978-3-319-51523-6_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Adiga CP, Gyanchandani M, Goolahally LN, Itagi RM, Kalenahalli KV. Endometrial stromal sarcoma: An aggressive uterine malignancy. J Radiol Case Rep 2016;10:35-43. [PMID: 27761197 DOI: 10.3941/jrcr.v10i9.2770] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
21 Hrzenjak A. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 2016;11:15. [PMID: 26879382 DOI: 10.1186/s13023-016-0400-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
22 Uterine Sarcomas. Diagnostic Pathology: Molecular Oncology 2016. [DOI: 10.1016/b978-0-323-37678-5.50175-4] [Reference Citation Analysis]
23 Lin H, Zhang M, Yu H, Zhang H, Li Y, Xu J, Chen X, Chen Y. Analysis of differentially expressed genes between endometrial carcinosarcomas and endometrioid endometrial carcinoma by bioinformatics. Arch Gynecol Obstet 2016;293:1073-9. [PMID: 26374646 DOI: 10.1007/s00404-015-3880-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Pautier P, Nam EJ, Provencher DM, Hamilton AL, Mangili G, Siddiqui NA, Westermann AM, Reed NS, Harter P, Ray-Coquard I. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus. Int J Gynecol Cancer. 2014;24:S73-S77. [PMID: 25341584 DOI: 10.1097/igc.0000000000000281] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 5.6] [Reference Citation Analysis]
25 Lee C, Nucci MR. Endometrial stromal sarcoma - the new genetic paradigm. Histopathology 2015;67:1-19. [DOI: 10.1111/his.12594] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
26 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
27 Song G, Yan J, Li G, Chen ZJ. Association between KIAA0319L, PXK and JAZF1 gene polymorphisms and unexplained recurrent pregnancy loss in Chinese Han couples. Reprod Biomed Online 2015;30:275-80. [PMID: 25596907 DOI: 10.1016/j.rbmo.2014.12.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Ali RH, Al-safi R, Al-waheeb S, John B, Al-ali W, Al-jassar W, Al-mulla F, Melnyk N, Huntsman DG, Lee C. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait. Human Pathology 2014;45:2453-62. [DOI: 10.1016/j.humpath.2014.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
29 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
30 Sciallis AP, Bedroske PP, Schoolmeester JK, Sukov WR, Keeney GL, Hodge JC, Bell DA. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 2014;38:1161-72. [PMID: 25133706 DOI: 10.1097/PAS.0000000000000256] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
31 Spindle-cell and myxoid lesions. Diagnosis of Neoplasia in Endometrial Biopsies 2014. [DOI: 10.1017/cbo9781139628976.006] [Reference Citation Analysis]
32 Hrzenjak A, Dieber-Rotheneder M, Moinfar F, Petru E, Zatloukal K. Molecular mechanisms of endometrial stromal sarcoma and undifferentiated endometrial sarcoma as premises for new therapeutic strategies. Cancer Lett 2014;354:21-7. [PMID: 25128649 DOI: 10.1016/j.canlet.2014.08.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
33 D'Angelo E, Prat J. Diagnostic use of immunohistochemistry in uterine mesenchymal tumors. Semin Diagn Pathol 2014;31:216-22. [PMID: 24863031 DOI: 10.1053/j.semdp.2014.03.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
34 Stewart CJR, Leung YC, Murch A, Peverall J. Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases. Histopathology 2014;65:473-82. [DOI: 10.1111/his.12406] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
35 Feng W, Malpica A, Skaland I, Gudlaugsson E, Robboy SJ, Dalen I, Hua K, Zhou X, Baak JP. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One 2013;8:e75899. [PMID: 24146786 DOI: 10.1371/journal.pone.0075899] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
36 Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013;62:124-37. [PMID: 23240674 DOI: 10.1111/his.12048] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]